Welcome to the Laboratory for Molecular Infection Medicine Sweden (MIMS)
The Nordic EMBL Partnership for Molecular Medicine
MIMS is the Swedish node of the Nordic EMBL Partnership for Molecular Medicine. This partnership was established in 2007 as a joint venture between the European Molecular Biology Laboratory (EMBL) and the Universities of Helsinki, Finland, Oslo, Norway and Umeå, Sweden. On March 5th 2013 a partner at the University of Aarhus, Danmark, joint the partnership and a new Nordic EMBL partnership agreement for a 10-year period was signed. The partnership between EMBL, the Institute for Molecular Medicine Finland (FIMM), the Centre for Molecular Medicine Norway (NCMM), the Danish Research Institute of Translational Neuroscience (DANDRITE) and the Laboratory for Molecular Infection Medicine Sweden (MIMS) is dedicated to the growing field of life sciences that investigates the molecular basis of disease and explores molecularly and genetically based treatments.
The aim of this new initiative is to strengthen Swedish research and enhance the dynamics in the field of molecular medicine, partly by promoting the career opportunities for young scientists.
Antti Vaheri, Prof. Dr.
University of Helsinki, Finland
Thomas F. Meyer, Prof. Dr.
Max Planck Institute for Infection Biology
Manuela Raffatellu, Assistant Professor
Department of Microbiology and Molecular Genetics
Institute for Immunology
University of California Irvine
The registration is now open!
(deadline for abstract submission 21 March, for participation 5 April)
More information: http://www.mims.umu.se/en/nib-2014.html